Omnicare Inc. to Pay Over $28 Million to Settle Kickback Allegations
As announced on Monday, October 17, 2016, by the United States Department of Justice (“DOJ”), the nation’s largest nursing home…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Long-Awaited MACRA Rule Released
On Friday, October 14, 2016, the Department of Health and Human Services (HHS) finalized its rule on the Medicare Access and CHIP…
EFPIA HCP Financial Disclosure Is Not Risk Free
A large number of pharmaceutical companies across Europe had until June 30, 2016 to disclose their financial interactions with…
MACRA Final Rule to Be Released Today – Promises to Bring a New Level…
According to Politico, this morning Friday October 14, 2016 the MACRA final rule is being released by HHS.
While the final…
What You Don’t Know About AMP Can Hurt You – Part 3 Can You Defend…
As part of a three-part series on the Average Manufacturer Price (AMP), this month’s article explores the continuing and evolving…
HHS Issues Open Government Plan
On October 6, 2016, the U.S. Department of Health and Human Services announced its fourth Open Government Plan, which details…
Mylan Reaches Deal Over EpiPen Rebates
On October 7, 2016, Mylan announced it reached an agreement with the United States Department of Justice (DOJ) to settle claims…
Getting to the Hub of the Matter: Analyzing the Compliance Needs for Hub…
Within the pharmaceutical industry there are new operating models emerging. One form of emerging arrangement is the increasing use…
FDA Issues Draft Guidance on Real-World Data
In September, FDA issued a draft guidance to clarify how it evaluates real-world data to determine whether it can be used in FDA…
The Debate Rages On: Should Clinical Trial Data Be Public?
As we have previously written, the topic of whether or not researchers should make all the data they collect when testing drugs…